Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences - Wikidata - awgldk - TriplyDB

Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences

Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences

http://www.wikidata.org/entity/Q27477971

about

Viral Determinants of Resistance to Treatment in Patients with Hepatitis C Pretreatment Sequence Diversity Differences in the Full-Length Hepatitis C Virus Open Reading Frame Correlate with Early Response to Therapy Mutations in E2-PePHD, NS5A-PKRBD, NS5A-ISDR, and NS5A-V3 of Hepatitis C Virus Genotype 1 and Their Relationships to Pegylated Interferon-Ribavirin Treatment Responses Genetic variation of hepatitis C virus in a cohort of injection heroin users in Wuhan, China Genetic Variability of Hepatitis C Virus before and after Combined Therapy of Interferon plus Ribavirin Evidence of Recombination in Intrapatient Populations of Hepatitis C Virus A set of reference sequences for the hepatitis C genotypes 4d, 4f, and 4k covering the full open reading frame Genetic diversity of NS5A protein from hepatitis C virus genotype 3a and its relationship to therapy response Genetic heterogeneity of hepatitis C virus in association with antiviral therapy determined by ultra-deep sequencing Evasion of intracellular host defence by hepatitis C virus Baseline prediction of combination therapy outcome in hepatitis C virus 1b infected patients by discriminant analysis using viral and host factors Regulation of PKR by HCV IRES RNA: importance of domain II and NS5A Single nucleotide polymorphisms of the IL28B and sustained virologic response of patients with chronic hepatitis C to PEG-interferon/ribavirin therapy: A meta-analysis: Meta-analysis of IL28B.Quantitation of substitutions at amino acid 70 in hepatitis C virus genotype 1b.Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy.Sequence heterogeneity in NS5A of hepatitis C virus genotypes 2a and 2b and clinical outcome of pegylated-interferon/ribavirin therapy Evolution of interferon-based therapy for chronic hepatitis C.Predicting the probable outcome of treatment in HCV patients.Analysis of HCV quasispecies dynamic under selective pressure of combined therapy.Sequencing of the Hepatitis C Virus: A Systematic Review.Relevance of baseline viral genetic heterogeneity and host factors for treatment outcome prediction in hepatitis C virus 1b-infected patients Prediction of hepatitis C virus interferon/ribavirin therapy outcome based on viral nucleotide attributes using machine learning algorithms.A novel approach to identify candidate prognostic factors for hepatitis C treatment response integrating clinical and viral genetic data.Sequence diversity of hepatitis C virus: implications for immune control and therapy.Effect of Hepatitis C Virus Genotype 1b Core and NS5A Mutations on Response to Peginterferon Plus Ribavirin Combination Therapy Kinetic response of wild and mutant core codon 70 strains of HCV genotype 1b to pegylated interferon-α and ribavirin therapy Genetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy.The Association of Substitutions in the Hepatitis C Virus Subtype 1b Core Gene and IL28B Polymorphisms With the Response to Peg-IFNα-2a/RBV Combination Therapy in Azerbaijani Patients.Resistance mechanisms in HCV: from evolution to intervention.Amino Acid Polymorphisms Within the Entire HCV NS5A Region in Estonian Chronic HCV 1b Patients With Different Treatment Response.HCV genetic variability: from quasispecies evolution to genotype classification.The natural history of early hepatitis C virus evolution; lessons from a global outbreak in human immunodeficiency virus-1-infected individuals.IL28B polymorphism and genetic biomarkers of viral clearance in hepatitis C virus infection.Natural killer cells in hepatitis C virus infection.Epistatic connectivity among HCV genomic sites as a genetic marker of interferon resistance.Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview.The role of HCV proteins on treatment outcomes.Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus.Sequencing of E2 and NS5A regions of HCV genotype 3a in Brazilian patients with chronic hepatitis.Induction of IL-6 and CCL5 (RANTES) in human respiratory epithelial (A549) cells by clinical isolates of respiratory syncytial virus is strain specific.

P2860

Q27478062-E5A0519E-5C7D-4084-989E-D7615986EB30 Q27481007-1761D477-5D06-48EE-BC51-E7C10D1EB150 Q27486410-F87EB3C2-B45F-4D03-AE86-43B8718865FF Q27486520-42E744DE-4A76-46CE-9EE0-11346ABFF348 Q27486648-D542EA3A-B4D9-4C6A-8FD1-D836BF112E62 Q27486806-D903EF1D-68AE-46B2-A847-96696DB40EB8 Q27490902-87FA9546-835A-4469-94A6-CFAC416408D8 Q27491275-1BC07D2F-C127-4CA6-BA7A-25DF59587A64 Q28477175-07C94C19-81A0-4935-B363-9EE87B66F3F3 Q29618976-C1B4865C-0A37-44F1-A877-AB2D642F7257 Q33770280-2EEF071B-8ACC-410C-968A-95BECB0AEB74 Q33987197-F0EE4841-FD81-4A26-BCD4-28171ECFD17C Q34075388-1B9969F6-E197-4690-9D7E-E9A526328EF9 Q34079153-A0C26218-B651-40EA-B1CF-39CB097B7E53 Q34099523-9FC9BFDD-B5E8-4067-A665-7EDEACE63276 Q34154593-EFE627A3-8154-4C24-AEBD-06A69B169EA6 Q34342092-E2013515-F780-4EE7-B8C5-2A679A7C0B98 Q34409039-D3543BE6-28F2-4577-A591-80E98E8B755B Q34572396-AB88C7A1-F23D-48EA-9466-F5790CCEFE9B Q34796385-66E3B0C2-37F9-496C-8C95-43B598A02204 Q34981566-2CBFA607-B495-4727-B3A1-C1B750FA9390 Q35230421-BA1BA5A6-316A-48D1-AA4D-FC5F54F19F13 Q35579175-0929F18A-06FA-45B9-9C69-A4E9B67586AB Q36179696-D9B6BC55-0255-4DC6-8796-60FD410DC6E4 Q36184075-F2572217-73C6-43D4-9C98-B609A631C7E5 Q36383353-59ECB105-6A86-4B33-8525-A4AB8CC3B6F1 Q36841724-28D3D8D5-472A-4482-822E-C9B936A40010 Q37006233-BF598BCC-103E-4FE8-A9AD-5037447A4402 Q37228736-99457202-4E29-4A66-92BE-4C3FE7D1C030 Q37401160-6A73FF46-37D0-4393-9FB6-6B8F7C027CB1 Q37425275-5CAF69A7-09FA-41F9-9E5B-278D863F8880 Q37903174-2898BD38-3665-4D90-859B-796687B7D15D Q37921307-3930B57F-A7C7-47F4-BC84-4431AD746067 Q38061192-289E4649-0887-41D4-BDFB-E596455F345D Q38074272-517D386E-C61E-4A42-899D-4C44027D4BAA Q38224436-61B71818-1A6E-443B-BCB3-9CCB80636336 Q38668968-370FC553-10CB-4A78-9856-3CD9634FCC78 Q38844558-CB9E7FC2-7523-4A98-BC63-2F52E62D0E74 Q39208854-5D4F59C8-2DFF-48BC-8022-9BCE25511082 Q39282294-87CBBFC6-9817-4E38-9DC7-EA1B86DE69E2

P2860

Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences

http://www.wikidata.org/entity/Q27477971

description

2004 nî lūn-bûn

@nan

2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Sustained virological response ...... ed on geographical differences

@ast

Sustained virological response ...... ed on geographical differences

@en

Sustained virological response ...... ed on geographical differences

@nl

type

label

Sustained virological response ...... ed on geographical differences

@ast

Sustained virological response ...... ed on geographical differences

@en

Sustained virological response ...... ed on geographical differences

@nl

prefLabel

Sustained virological response ...... ed on geographical differences

@ast

Sustained virological response ...... ed on geographical differences

@en

Sustained virological response ...... ed on geographical differences

@nl

P1433

Q27477971-31EFA3FF-5184-4F3C-BAB3-0D6F13D24ACB

P1476

Q27477971-5B42DBAF-7DEA-46ED-952F-3AB23F4FEBB4

P2093

Q27477971-56BC4AA9-1C4F-482E-A108-AB7621ABB4FE

Q27477971-7C3BBBD7-734B-4247-B356-19C89F80991D

Q27477971-7E839EE3-111B-4F91-B3B7-359C707A43BA

Q27477971-8AA9A4EF-FBBF-4165-8CDF-24EC84152DD2

Q27477971-C317ABC5-F9CD-45DE-97EC-8D96E303EBDB

Q27477971-EBEBF2FA-3322-481D-9424-3AD456588D77

P2860

Q27477971-00EFD579-361B-4DD7-97A8-E0C7C258169D

Q27477971-0B1E9484-CCBD-41AD-B1FF-45AE3AACC627

Q27477971-0E8C7A6F-9D83-481A-82A6-C038E46FAA94

Q27477971-113A6A3B-F1EB-4AAF-9F9A-602BB1C05318

Q27477971-2925212A-BF53-4FC9-A8CB-EB9613302704

Q27477971-2D979F3D-98A8-44D2-B123-2AAB91241E4D

Q27477971-30026957-B527-4FDA-8FD1-C8F6113964A8

Q27477971-305FFC3B-A9FC-4E3B-BAC7-77174CCF90F8

Q27477971-316D6365-29C5-4186-8E4D-BEA0E590E6A1

Q27477971-3240A4E8-426A-41BA-9CB6-13DB910F6D3E

P304

Q27477971-46F13B78-B359-4AFC-8C48-621F03C15392

P31

Q27477971-70D58B5B-7969-4354-87B9-D04C9A735329

Q27477971-8F58469C-2DFE-4FFA-9A98-5212D1A8470C

P3181

Q27477971-E2266A0E-07F3-4119-BAE7-1143D58A78DC

P356

Q27477971-F541432D-2774-4932-991D-15E0BF74B22F

P407

Q27477971-7F0821C5-AF55-4067-B900-3C4A6B6B90EB

P433

Q27477971-F9FFE412-C44C-4B23-90D8-C5A525FE0DDA

P478

Q27477971-8339D2DD-2718-4F7B-8140-A134B4BCB8F7

P50

Q27477971-DC52AA98-828F-4BDE-9DB9-E553585B065F

P577

Q27477971-BA2DF76F-432A-4482-8133-DC7756FFE49D

P5875

Q27477971-17679496-DA54-4D88-81EA-F467AC674518

P698

Q27477971-53B5C88E-0F28-4B49-8963-47CF792C1271

P921

Q27477971-69F60F45-EDF3-4656-BAC5-7F4BD485EA93

Q27477971-94E609F7-960B-4FD0-827E-CA4961524F04

Q27477971-C2111C88-D811-414D-BAD7-D9586C7B07EF

P932

Q27477971-822B30FB-329F-4DD0-8530-DA464A16266A

P3181

P356

GUT.2003.031336

P1433

P1476

Sustained virological response ...... ed on geographical differences

@en

P2093

B Wiedenmann

http://www.w3.org/2001/XMLSchema#string

E Schreier

http://www.w3.org/2001/XMLSchema#string

M Höhne

http://www.w3.org/2001/XMLSchema#string

M Pascu

http://www.w3.org/2001/XMLSchema#string

P Martus

http://www.w3.org/2001/XMLSchema#string

U Hopf

http://www.w3.org/2001/XMLSchema#string

P2860

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

A simple method for displaying the hydropathic character of a protein

Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy

Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation.

Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses.

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

The non-structural 5A protein of hepatitis C virus.

P304

1345-1351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2123275

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/GUT.2003.031336

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8403886

http://www.w3.org/2001/XMLSchema#string

P698

15306598

http://www.w3.org/2001/XMLSchema#string

P921

P932

1774214

http://www.w3.org/2001/XMLSchema#string